Conservative therapy is often the first-line treatment for many symptoms of various disease processes, including pain. Nevertheless, if pharmacological or medical management fails for those patients with severe and chronic pain, a surgical strategy may be a reasonable option. First performed for psychiatric disorders, cingulotomy now has been recognized as a viable option for the management of pain. The authors review the literature on anterior cingulotomy for intractable pain to provide guidelines for management and expected outcomes.
Introduction
Conservative therapy is often the first-line treatment for many symptoms of various disease processes, including pain. Nevertheless, if pharmacological or medical management fails for those patients with severe and chronic pain, a surgical strategy may be a reasonable option. Amongst the surgical options there are neuromodulation or neuroablative procedures, including cingulotomy [1] . First performed for psychiatric disorders, cingulotomy now has been recognized as a viable option for the management of pain. Bilateral cingulotomy targets the anterior cingulate cortex, a part of the limbic system controlling integration of feelings and emotion [2] . As with other ablative procedures, concern exists regarding the destructive nature of the procedure and uncertainty regarding its mechanism of action. As such, the authors review the literature since the 1990s on anterior cingulotomy for intractable pain to provide guidelines for management and expected outcomes.
Historical perspectives
Following the introduction of frontal lobotomy by Egas Moniz in the mid-1930s, interest in decreasing the associated morbidity and mortality of the psychiatric surgery led physicians to search for alternative approaches that would still realize the desired psychiatric changes [3] . The concept of a cingulotomy was introduced by American physiologist John Fulton at a meeting of the Society of British Neurosurgeon in 1947. As Fulton stated, "were it feasible, cingulectomy in man would seem an appropriate place for limited leucotomy" [4] . In 1948, Cairns performed the first anterior cingulectomy [5] . The results of 15 of these operations for a variety of psychiatric illnesses by Cairns and his colleagues were reviewed by Lewin in 1961 [6] . In 1962, Foltz and White reported a case series of patients who underwent stereotactic cingulotomy for intractable pain [4] . Later, Ballantine et al. reported complications in a series of 12 patients with intractable pain; however, no deaths were attributable to their technique [4] . Finally, in 1968, Foltz and White utilized anterior bilateral stereotactic cingulotomy extensively in their report on patients in whom "incapacitating pain seemed to be significantly augmented by emotion factors." [7] .
Surgical procedure
Originally performed using ventriculography, cingulotomy is now conducted using magnetic resonance image (MRI) guided stereotactic technique. Direct visualization of targeted tissue clearly favors MRI guided stereotactic techniques. Preoperative preparation includes mapping out the cingulate cortex. Under intravenous sedation with local anesthesia at pin insertion sites, a stereotactic MR-compatible frame is fixed to the patient's skull. Utilizing oblique coronal MR images, tissue of the anterior cingulate gyrus is targeted approximately 2 to 2.5 cm posterior to the tip of the frontal horn, 7 mm from the midline and 2 to 3 mm above the corpus callosum bilaterally [8] .
The patient is then placed on the operating table in a supine or semireclining position and the stereotactic frame is secured into position. Following skin incision, burr holes are drilled 15 to 25 mm from the midline. The dura is opened with caution to avoid cortical vessels. The thermocoagulation electrodes are inserted under stereotactic guidance (Fig. 1) . The target tissue is heated to 85 degrees Celsius for 90 s utilizing a standard thermocoagulation electrode (Radionics, Inc., Burlington, 
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Interdisciplinary Neurosurgery: Advanced Techniques and Case Management j o u r n a l h o m e p a g e : w w w . i n a t -j o u r n a l . c o m MA) with a 10 mm uninsulated tip. After cooling, the electrode is withdrawn approximately 5 to 10 mm whereby a second lesion is made in accordance with the parameters for the initial lesion. The aforementioned procedure is then completed in an identical manner for the contralateral side ( Fig. 2a and b) . Of note, in recent years, three lesions are placed to ensure complete ablation and reduce the need for subsequent lesioning procedures [8] .
Methods
We searched the following electronic databases: PubMed, CENTRAL (The Cochrane Library), MEDLINE, and EMBASE. Our search terms were "anterior cingulotomy" and "cingulotomy pain." No language restriction was implemented. Patients must have pain refractory to pharmacological or medical management. Outcome was alleviation of symptoms per the patients.
Results

Literature search
The combined search strategy identified 365 records (Fig. 3) . After review, 9 articles investigating change in severity of intractable pain following anterior cingulotomy were identified (Table 1) .
Patient outcomes
Half of the patients in the studies reviewed received bilateral anterior cingulotomy for non-cancer pain (41 patients) versus cancer pain (41 patients). A wide variety of non-cancer indications for cingulotomy were reported and included post-traumatic neuropathic pain, atypical facial pain, diabetic neuropathy, and phantom pain. The majority of studies we reviewed used MRI for localization, although two reported use of computed tomography (CT). Quantification of pain improvement was uneven between studies -two studies used the Visual Analog Scale (VAS), one used a 10 point Likert scale, and one used the McGill pain scale. Improvement in pain following cingulotomy was reported to range from 50 to 100% overall with similar results between cancer pain and non-cancer patients [1, [9] [10] [11] [12] [13] [14] [15] [16] .
Discussion
Postoperative pain relief following anterior cingulotomy has been cited as temporally bimodal. Following their procedure, patients may be confused and ignore their pain. However, as the confusion clears the pain may return. Ultimately, patients may become habituated towards their pain [2] . Patients must be carefully followed with serial neurological examinations for early detection of any complications. An immediate, postoperative MRI scan is recommended to document the lesion site, lesion volume, and detect any complications. Patients recover well enough for discharge from the procedure after approximately 4 days, but some report recovery in as little as 48 h postoperatively. Although anterior cingulotomy demonstrates effectiveness in pain control, surveillance for adverse effects is important. Observed side effects include headaches, nausea, vomiting, and seizures [17] . While a spectrum of cognitive side effects have been reported following cingulotomy, cases with no adverse effects have been documented [18] . In a controlled trial on patients treated with cingulotomy for intractable pain, Cohen et al. reported postoperative executive and attention impairments. On one-year follow-up, the aforementioned deficits mostly resolved, with residual impairments of intention, attention, and spontaneous response production [12] . Additional reports have cited cognitive side effects with defects in visual-spatial processing and simple motor skills [19, 20] .
Conclusion
Bilateral anterior cingulotomy is generally used when more conservative medical, surgical, and pharmacological methods have not succeeded. First utilized for patients with psychiatric problems such as anxiety, obsessive-compulsive disorders, and depression, anterior cingulotomy has for several decades been a treatment option for chronic pain. Given its ability to provide relief to any body region, anterior cingulotomy proves to be a versatile therapeutic strategy. Patients often recover relatively quickly with self-limited complications. Overall, stereotactic bilateral anterior cingulotomy has been demonstrated to be efficacious for the treatment of refractory and intractable pain.
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